RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 84 filers reported holding RELMADA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q3 2022 | $617,000 | +81.5% | 16,680 | -6.9% | 0.00% | – |
| Q2 2022 | $340,000 | -28.9% | 17,922 | +1.3% | 0.00% | – |
| Q1 2022 | $478,000 | +94.3% | 17,696 | +62.2% | 0.00% | – |
| Q4 2021 | $246,000 | +6.5% | 10,907 | +51.0% | 0.00% | – |
| Q2 2021 | $231,000 | -9.1% | 7,223 | +0.3% | 0.00% | – |
| Q1 2021 | $254,000 | -33.7% | 7,204 | -39.8% | 0.00% | – |
| Q4 2020 | $383,000 | +71.0% | 11,975 | +100.8% | 0.00% | – |
| Q3 2020 | $224,000 | -36.9% | 5,963 | -25.0% | 0.00% | – |
| Q2 2020 | $355,000 | – | 7,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |